Australia vs United States of America: Number of isolates tested for ceftriaxone
Australia
7,222
in 2020
United States of America
3,741
in 2020
Australia rank
1st
United States of America rank
2nd
Number of isolates tested for ceftriaxone over time
- Australia
- United States of America
How they compare
Australia currently reports 7,222 against 3,741 in United States of America, a difference of 3,481.
That makes Australia's figure about 1.9 times United States of America's.
The two have swapped places 1 time across 11 shared years of data; in 2009 it was United States of America ahead.
Australia ranks 1st and United States of America ranks 2nd of 52 countries.
Across the 3 decades both report, Australia averaged higher in 2 and United States of America in 1.
Head to head by decade
| Decade | Australia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3,157 | 5,630 | 2,473 | United States of America |
| 2010s | 5,607 | 5,369 | 238.67 | Australia |
| 2020s | 7,222 | 3,741 | 3,481 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Australia or United States of America?
- Australia, at 7,222 against 3,741 in United States of America as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Australia and United States of America?
- 3,481, with Australia ahead.
- How many years of comparable data are there for Australia and United States of America?
- 11 years are reported by both, from 2009 to 2020.
- How do Australia and United States of America rank globally for number of isolates tested for ceftriaxone?
- Australia ranks 1st and United States of America ranks 2nd of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.